Inositol

    • Product Name: Inositol
    • Alias: vitamin B8
    • Einecs: 200-738-9
    • Mininmum Order: 1 g
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications

    HS Code

    107510

    Name Inositol
    Chemical Formula C6H12O6
    Molecular Weight 180.16 g/mol
    Appearance White crystalline powder
    Solubility In Water Very soluble
    Taste Slightly sweet
    Melting Point 224-227°C
    Cas Number 87-89-8
    Ph Value 6.0-7.5 (1% solution)
    Synonyms Myo-inositol, Vitamin B8

    As an accredited Inositol factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing White, sealed HDPE bottle labeled "Inositol, 100g." Features product details, batch number, safety warnings, and manufacturer contact information.
    Shipping Inositol is shipped in sealed, moisture-resistant containers, typically in fiber drums or plastic bags, to prevent contamination and degradation. It should be stored and transported in a cool, dry place, away from strong oxidizers. Proper labeling and documentation are required to ensure safe handling and compliance with chemical shipping regulations.
    Storage **Inositol** should be stored in a tightly closed container, in a cool, dry, and well-ventilated area away from moisture, heat, and direct sunlight. It should be kept away from incompatible substances like strong oxidizing agents. Proper labeling and secure storage are essential to maintain its stability and prevent contamination or degradation. Always follow standard laboratory safety protocols.
    Application of Inositol

    Applications of Inositol in Industrial Manufacturing

    As a direct manufacturer of Inositol, we supply consistent, high-purity material to core sectors that rely on precise formulation, regulatory compliance, and proven downstream integration. Here, we outline the proven industrial scenarios and processing requirements for Inositol according to the current standards and the evolving regulatory landscape anticipated up to 2026.

    1. Infant Formula and Pediatric Nutritional Manufacturing

    Inositol serves as a conditionally essential nutrient in the production of infant formula, closely matching human milk composition. Major pediatric nutrition producers use it to support normal growth and neural development in newborns. The ingredient enters the process at the wet blending or dry blending stages, depending on the formula design, under strict compliance with food safety and nutritional guidelines for infant products globally.

    Industry compliance standards

    • Codex Alimentarius Standard for Infant Formula (CODEX STAN 72-1981, updated versions)
    • GB 10765-2021 (China National Food Safety Standard for Infant Formula)
    • EU Regulation (EU) 2016/127 for Infant and Follow-on Formula
    • US FDA 21 CFR Part 106 and 21 CFR 107

    Typical usage ratio

    • Typically between 22–45 mg/100 kcal, aligned with international nutritional recommendations for infant formula. Dosage is adjusted according to final product energy density and local regulations.

    Downstream process integration

    • Added during wet blending of aqueous phase or dry-blending after pasteurization; mixing occurs before spray drying, ensuring uniform distribution. Final QC verifies inositol content per batch.

    Final product types

    • Infant formula powders
    • Follow-on formula
    • Ready-to-feed liquid formula

    2. Pharmaceutical Tablet and Oral Solution Manufacturing

    Inositol functions as both an active ingredient and excipient in medicinal products aimed at neurological, metabolic, and reproductive indications. Pharmaceutical manufacturers apply it in GMP-controlled facilities for solid oral tablets, granules, and oral liquids, ensuring consistent dosing. Its inclusion follows pharmacopeial quality specifications, and precise SOPs guide its introduction during early blending or solution preparation.

    Industry compliance standards

    • USP-NF (United States Pharmacopeia – National Formulary Monograph for Inositol)
    • Ph. Eur. (European Pharmacopoeia 10th edition and later)
    • Chinese Pharmacopoeia (ChP)
    • GMP for Pharmaceuticals (ICH Q7, EU GMP Annex 13 for Investigational Products when applicable)

    Typical usage ratio

    • Active: 250 mg–4 g per daily dose, adjusted for indication
    • Excipient: typically 2–10% of tablet/capsule filler composition
    • Solution: dissolved at 1–5% w/v, depending on product type

    Downstream process integration

    • Integrated in dry powder blending for tablet granulation or dissolved during oral solution compounding; final steps include filtration, granule compression, or liquid filling.

    Final product types

    • Coated and uncoated tablets
    • Oral sachet granules
    • Oral liquid solutions and syrups

    3. Food and Beverage Fortification

    Functional and wellness beverage producers incorporate Inositol to support energy metabolism claims and enhance nutrient profiles. Its stability and quick solubility make it suitable for high-throughput beverage blending and health food enrichment. Food technologists monitor the addition to comply with label claims and ensure regulatory adherence, balancing dosage for flavor neutrality and nutrition label requirements.

    Industry compliance standards

    • Regulation (EC) No 1925/2006 on the addition of vitamins and minerals (EU)
    • China GB 14880-2012 for Food Nutritional Fortification Substances
    • FDA 21 CFR 184.1370 for Direct Food Substances Affirmed as Generally Recognized as Safe (GRAS)
    • FSSC 22000 and HACCP systems for food processing facilities

    Typical usage ratio

    • Enrichment: 40–100 mg per serving in functional drinks
    • Bakery and cereal: 0.01–0.05% (w/w) based on finished batch; precise ratio adjusted by product category and labeling limits

    Downstream process integration

    • Added during final beverage blending, pre-filling, or post-baking enrobement, depending on temperature tolerance and process sequence; dissolves rapidly for cold or hot applications.

    Final product types

    • Ready-to-drink functional beverages
    • Energy drinks
    • Fortified breakfast cereals and snack bars
    • Nutritional powder blends

    4. Feed Additive Production for Specialized Animal Nutrition

    Pet food and aquaculture feed manufacturers add Inositol to formulations for growth performance, reproductive health, and immune function. Its use is particularly essential in fish larval diets and ornamental aquatic species as well as in specialized pet formulas. The additive enters during the premix blending stage, adhering to precise dosage protocols and audit requirements under global feed additive control systems.

    Industry compliance standards

    • EU Regulation (EC) No 1831/2003 for Feed Additives
    • AAFCO Official Publication (US, relevant animal feed ingredient definitions)
    • China GB/T 17810 – Additives for Animal Feeding
    • FAMI-QS Code (Feed Additives and Premixtures Quality System)

    Typical usage ratio

    • 0.02–0.15% of total feed mass for aquaculture starter feeds
    • 10–30 mg/kg diet in pet food, with exact inclusion adjusted for species, age, and growth stage

    Downstream process integration

    • Incorporated in vitamin/mineral premix before extrusion or pelleting; dosing and mixing validated by batch record; final product undergoes uniformity checks for micronutrient distribution.

    Final product types

    • Extruded fish feed for hatchery and juvenile production
    • Pelleted ornamental aquatic feed
    • Pet food for dogs, cats, and specialty animals

    5. Culture Media Preparation for Industrial Fermentation

    Biopharmaceutical and microbial fermentation industries use Inositol as a key growth factor in culture media for microbial and mammalian cell cultivation. It contributes to cell viability and productivity, particularly during mammalian cell-based bioprocess production of recombinant proteins, vaccines, and monoclonal antibodies. The ingredient is dosed precisely to maintain optimal culture performance in large-scale fermenters under cGMP protocols.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • USP <1043> Ancillary Materials for Cell, Gene, and Tissue-Engineered Products
    • ISO 13408-1 for aseptic processing in biological manufacturing
    • Relevant national microbial nutrient standards

    Typical usage ratio

    • 5–50 mg/L in mammalian cell culture media; exact level optimized based on cell line requirements and process productivity data.

    Downstream process integration

    • Sterile addition to media preparation tank prior to autoclaving or sterile filtration; process monitored for concentration and homogeneity. Periodic validation ensures no deviation from setpoints during scale-up.

    Final product types

    • Chemically defined cell culture media for monoclonal antibody production
    • Microbial fermentation broths for biotechnology
    • Recombinant protein and enzyme production systems

    Free Quote

    Competitive Inositol prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: admin@ascent-chem.com

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Inositol: A Manufacturer’s View on Quality and Application

    Introduction to Inositol in Our Portfolio

    Inositol comes up often in daily work, conversations with buyers, and planning sessions on the production floor. Among the powders we handle, this one stands out for its role in high-value segments such as food, pharmaceuticals, and feed. Through years of manufacturing, we’ve learned to keep an eye not only on the numbers in the QC lab, but also on the types of needs coming in from end-users and partners who actually rely on this ingredient.

    Model and Application-Specific Guidance

    Our D-Chiro and Myo-Inositol lines serve very different industries, but production approach roots itself in the same foundation: tight control of process, traceability, and honest communication with customers. We offer crystalline and fine powder forms, with particle size ranging from coarse granules down to microfine powder. Most batches come between 99.0% and 99.5% purity, measured by HPLC. Particle size cuts matter—a nutrition customer prefers the microfine for instant drink blends, while tablet makers stick to granular batches to prevent dust-up and sticking during compression.

    On the pharma side, our bottling partners tend to ask for Myo-Inositol, meeting USP or EP standards, and tested to ensure low moisture and absence of heavy metals above regulatory thresholds. We don’t just produce to spec; there’s a deep focus on cross-checking microbial limits and checking batch homogeneity, especially when products are destined for children’s supplements or clinical nutrition formulas.

    Feed formulators prefer a different approach. Here, particle size and flow seem to matter less than the bulk cost per kilo or the ability to add it into complex premixes without causing caking. The feed inositol model follows national feed grade standards, but always gets shipped with a technical data report on production date, batch, and macronutrient content.

    Real-World Usage and Why Quality Features Matter

    Inositol isn’t just a shelf item—it gets used in everything from health drinks to intravenous solutions. Even small differences in physical characteristics create ripple effects in the customer’s setting. In soft beverage mixes, particle humidity and solubility end up dictating whether customers get a smooth drink or face annoying clumps at the bottom of the cup. Consistently low moisture keeps batch quality high, avoids shelf-life complaints, and helps our downstream partners avoid nasty surprises after their blends go to market.

    With pharmaceutical applications, it’s not just the purity that matters, but the absence of off-odors and chemical residues that only show up if the plant’s handling is tight. A couple of years ago, one client flagged an off-note—by tracing the batch back, we discovered a temperature fluctuation during drying. That prompted an overhaul of our in-line sensors in the drying section, as cutting corners on environmental controls clearly threatens both quality and longstanding relationships. Ever since then, our batch-to-batch repeatability tightened, and customer complaints dropped to zero.

    Food processors working on baby formula or health snacks focus on allergen absence as much as analytical purity. Here, the lessons learned running a gluten-free line for other products came in handy. Dedicated lines, thorough validation after each run, and regular training for all plant staff build the assurance that allergenic cross-contact stays out of the equation. Inositol’s role as a vitamin-like compound in infant formula means quality assurance gets audited not just by commercial partners, but often by outside agencies and, sometimes, government inspectors.

    Inositol vs. Other Carbohydrate Derivatives

    On the surface, inositol looks like another white powder—easy to confuse with glucose, sorbitol, or mannitol. In our QC labs and application tests, the technical feel is totally different. Inositol brings a unique set of sweetening characteristics because its taste profile sits much milder. Lab tests confirm that it sports a sweetness profile at about half that of sucrose. Some customers use it in products where you don’t want a strong sweet hit, but still want the osmotic and bulking properties, such as specialty drinks and kids’ oral supplements.

    Unlike mannitol, inositol’s stability over a wide temperature range makes it worth using in baked goods, granola bars, and instant flour mixes. We constantly get feedback from snack manufacturers about the product’s resistance to browning and burning in the oven, which comes from its lack of reducing sugar groups. That means it can pass through high-temperature processes, like extrusion or pan-baking, without creating off-flavors or darkening—an outcome we’ve physically compared with sorbitol and maltitol on our pilot manufacturing lines.

    From the processing side, inositol dissolves much faster and more thoroughly in water than mannitol or sorbitol under the same conditions. With pharmaceutical customers, dissolution tests run in our R&D lab show complete solubilization in minutes, even at cold temperatures. This matters a lot for parenteral or oral solution products, where incomplete dissolution can cause clarity issues or sediment, leading to entire production runs being scrapped.

    Customer Experiences and Lessons From Continuous Manufacturing

    Over the last decade, we’ve noticed certain trends: customers in premium food nutrition expect tighter and tighter specifications, not just for actives, but for trace and process impurities. Learning from a major beverage brand, we started performing per-batch trace metal analysis, reporting on lead, cadmium, arsenic, and mercury—even though only cadmium and lead ever approached regulatory thresholds. Sharing these results openly has built deeper relationships and trust on both ends, making technical dialogues smoother when customers want to tweak particle size or request a special packaging run.

    Each time we onboard a new API customer, we end up teaching their R&D team about the differences between inositol and common fillers. Many expect behavior similar to dextrose or fructose and are surprised by the minimized sweetness and excellent stability to heat and light. We’ve run storage studies at 40°C for six months, comparing color and taste to parallel samples of mannitol and glucose, noticing inositol’s edge in product integrity over time. This helps explain to customers why it might cost more upfront, but save hassles in downstream manufacturing and extend shelf life for finished products.

    Animal nutrition partners often teach us something new, too. A few years ago, a swine feed company outlined problems with caking in their automated feeders. Our technical team collaborated to create an inositol blend with enhanced flow agents, resolving dosing issues and eliminating downtime. Continuous feedback loops like this drive internal improvements and keep our engineers tuned to field realities.

    Quality Systems and Hands-On Practices

    Our workforce knows there’s no shortcut to high reliability in inositol production. Each production batch gets run through particle size distribution analysis, moisture content, microbiological testing for total counts, yeast, mold, and pathogens, as well as purity checks by HPLC and FTIR. Sampling gets double-checked not by a separate QC department miles away from the plant floor, but right next to the reactors and dryers, so any anomaly can be investigated and corrected fast. We operate with a real sense of pride—bad batches aren’t just losses, but a threat to the company’s reputation and, in the case of pharmaceutical use, the health of real people.

    Over time, we’ve built encounters with everything from glass fragments from a supplier’s bottle to small inconsistencies in lot blending. Each time, we take away lessons. Regular retraining and shift handoffs got more rigorous. Full vertical integration (from incoming raw material quarantine to final packaging) stays a cornerstone of reliable supply. We prepare detailed batch records—much more than just what’s required by standard GMP—so any hiccup can be traced down to the time, day, and operator involved.

    Direct line communication with major downstream processors sits at the heart of our best technical partnerships. These relationships don’t run just on price, but on constantly evolving needs for traceability, transparency, and honest troubleshooting. This means acknowledging imperfections rapidly, correcting processes, and updating documentation when even trace issues surface.

    Packaging, Shelf Life, and Logistical Considerations

    Our inositol goes out to the world packed in multi-ply fiber drums with inner liners, heat-sealed immediately after final drying and sieving. Finished product comes tested for residual moisture (targeting 0.5% or below) to ensure caking doesn’t become a concern in transit or storage. Over the years, logistics partners taught us a lot about temperature management in transit, particularly for bulk shipments moving in uncooled sea containers over long distances. A few incidents of condensation or sweating convinced us to invest in enhanced liners and better sealing equipment in our packaging hall.

    Shelf life remains one of the most important questions for global customers. We found that three-year stability claims hold up, provided storage follows recommended conditions: cool, dry, out of direct sunlight. Product that’s improperly stored, especially in humid regions, may see slight caking, but correct handling keeps every drum in spec and avoids unpleasant surprises when it finally gets opened at the point of use.

    Regulatory, Safety, and Compliance Questions

    Inositol’s regulatory status differs between countries and industry segments. For food use, our product meets the purity and residue specifications laid down by the FCC and JP standards, while pharmaceutical batches match the tighter requirements of USP, EP, ChP, and relevant monographs. For every shipment, documentation includes batch CoA, trace metal analysis, and allergen status report, because we know auditors check these files line by line.

    Dealing with regulation means more than just paperwork. It’s about installing systems that keep each parameter in line, whether it’s heavy metals, residual solvents, or microbiological safety. In practice, that means extra investments in analytical instrumentation, extra hands in the lab (especially at peak season), and consistent training of both QA and operations staff.

    Health and safety in the plant matter as well. We ensure dust control and monitor airborne particle concentrations, preventing respiratory risks to workers and limiting cross-contamination with other products. Allergens are strictly excluded, verified through line swabbing after any non-inositol runs. Traceability covers not just our own production batches, but all incoming raw materials and suppliers, tracked back to origin so any rare nonconformity can be swiftly dealt with.

    Environmental Considerations and Corporate Responsibility

    Running a chemical plant for inositol means balancing efficiency, economic needs, and responsible handling of waste. Our plant reclaims much of the water used in crystallization and washing through a closed-loop process, which keeps overall consumption down. Solid wastes, such as spent filter cake, go out only after full analysis—each batch checked for residual inositol content to recover as much as practical, and then handled according to regulatory frameworks as non-hazardous waste.

    Neighbors and community groups often have questions on effluent and emissions. Every couple of months, we host open days for local officials and interested members of the public to tour the plant, review environmental data, and raise questions. We deliver detailed annual reports on air, water, and noise emissions to local authorities, not just as a regulatory checkbox but to maintain credibility in the people’s eyes. In difficult cases, such as a sudden odor event due to a malfunction, we investigate root causes with urgency and report remediation steps clearly.

    Corporate sustainability means not just hitting the bottom line, but building a workforce that feels proud of what they produce. We found the best plant improvements and efficiency gains don’t come from consultants, but from experienced operators on the line. Their suggestions on chemical dosing, recycling, and shift handover procedures have yielded reductions in energy use and waste that outside experts never spotted.

    Innovation and Future Directions

    Customers today ask more about specialty blends, micronized forms, and combined nutraceutical products with inositol as a core component. We maintain an active R&D group that experiments with granulation, encapsulation, and microencapsulation to meet market needs for instantized or taste-masked inositol. Each new development runs parallel trials at the pilot scale, with feedback from longtime buyers feeding into iterative improvement cycles.

    There’s interest in custom derivatives, and for some markets, inquiries into manufacturer traceability for non-GMO or plant-based certification have picked up. We actively pursue documentation and testing that supports these requests, even when it means longer lead times or adjustments to raw material sourcing. The willingness to tailor products comes from a deep-seated belief that trusted supply partnerships go far beyond the contract—they grow from years of learning, exchange, and reliability.

    Final Thoughts on Inositol’s Place in Modern Manufacturing

    Across three decades of chemical manufacturing, inositol ranks as one of the most adaptable and quietly crucial products in our lineup. Handling it properly—without shortcuts and with deep attention to every detail—turns what could just be another commodity into an ingredient that keeps unlocking technical and business opportunities for our partners. Success here does not spring from fancy equipment alone, but from a plant culture of vigilance, communication, and readiness to respond directly to every challenge our customers and staff throw our way.

    We treat every drum, every sample, and every customer inquiry as a chance to do better than the last batch. From food and beverage launches to critical medical use, inositol stands as a testament to how manufacturing quality and customer alignment create impact well beyond factory gates—and that, to us, brings genuine satisfaction.

    Top